Abstract:The purpose of this study was to evaluate the long-term prognostic value of exercise technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission tomography (SPET) imaging in patients after percutaneous coronary intervention (PCI). Three hundred and eighteen consecutive post-PCI patients who underwent exercise and rest 99mTc-MIBI SPET myocardial perfusion imaging (MPI) were followed up for 38±27 months. Patients with early revascularisation (<3 months after MPI) were excluded. A semiquantitative visual analysis employing a 20-segment and four-point scoring system was used to define the summed stress score (SSS), summed rest score (SRS) and summed difference score (SDS). Death and non-fatal myocardial infarction (MI) were considered as hard events, and late revascularisation procedures (≥3 months after MPI) as soft events. Fifty-one patients (16.0%) suffered from cardiac events during follow-up, including 1 (0.3%) death, 13 (4.1%) non-fatal MIs, 9 (2.8%) coronary artery bypass grafting procedures and 28 (8.8%) PCIs. According to the SPET results, patients were classified into three groups: patients with normal MPI (SSS=0, n=153), patients with irreversible defects (SDS<3 and SRS>1, n=100) and patients with reversible defects (SDS≥3, n=65). The annual hard cardiac event rate in patients with reversible defects was 3.9%, which was significantly higher than that in patients with normal MPI (0.2%, χ2=7.71; P<0.01). The annual soft cardiac event rate in patients with reversible defects was 10.7%, which was significantly higher than that in patients with irreversible defects (2.5% χ2=17.69; P<0.001), and also significantly higher than that in patients with normal MPI (1.5%, χ2=33.89; P<0.001). In patients with normal and reversible defects, there was no significant difference in soft and hard cardiac event rates according to whether patients were symptomatic or asymptomatic (P>0.05). However, the annual soft event rate in patients with irreversible defects and symptoms was 5.0%, which was higher than that of 0.6% in asymptomatic patients (χ2=6.11, P<0.05). Multivariate Cox analysis showed that SSS was the best independent predictor for hard cardiac events (χ2=12.70; P<0.001) and SDS was the strongest independent predictor for soft cardiac events (χ2=11.72; P<0.001). Post-PCI patients who have normal exercise 99mTc-MIBI SPET MPI have a good long-term prognosis, while those with reversible defects are at a higher risk for future cardiac events, without correlation to the chest pain symptoms. However, symptomatic patients with irreversible defects have a higher risk for repeat revascularisation, but not for hard events, compared with asymptomatic patients. Exercise 99mTc-MIBI SPET MPI has important clinical value for risk stratification and management decision-making in post-PCI patients.

Correlation of current myocardial perfusion imaging and previous coronary angiography to avert the need for repeat intervention - A case report

Myocardial ischemia in patients with large prior infarction: Clinical decision making and review of literature

Prognostic value of hybrid cardiac perfusion SPECT/CT for patients with coronary artery disease after coronary artery bypass grafting

Prognostic Value of Gated Myocardial Perfusion Imaging for Patients after Percutaneous Coronary Intervention

Does myocardial perfusion imaging after revascularization have a role in risk stratification of heart rhythm abnormalities?

Myocardial perfusion imaging combined with computed tomography coronary angiography in the diagnosis and treat-ment of coronary heart disease

Clinical Outcomes of Dynamic Computed Tomography Myocardial Perfusion Imaging Combined with Coronary Computed Tomography Angiography Versus Coronary Computed Tomography Angiography-Guided Strategy

Impact of Incomplete Revascularization of Coronary Artery Disease on Long-Term Cardiac Outcomes. Retrospective Comparison of Angiographic and Myocardial Perfusion Imaging Criteria for Completeness

Role of Positron Emission Tomography Cardiac Perfusion Imaging in Clinical Management, Prognosis, and Risk Stratification of Cardiovascular Disease

CARDIAC CT–PERFUSION IMAGING IN MYOCARDIAL BRIDGING EVALUATION: A NOVEL WEAPON FOR NON–INVASIVE ASSESSMENT OF A SILENT KILLER

The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging

Comparison of Coronary Angiography with Myocardial Perfusion Imaging in Assessment of Functionally Relevant Coronary Artery Lesion

Advances in Myocardial Perfusion MR Imaging: Physiological Implications, the Importance of Quantitative Analysis, and Impact on Patient Care in Coronary Artery Disease

Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting

Value of 99m Tc-MIBI gated myocardial perfusion imaging before and after percutaneous coronary intervention

Long-term Prognostic Value of Exercise 99Mtc-Mibi SPET Myocardial Perfusion Imaging in Patients after Percutaneous Coronary Intervention.

Prognostic impact of myocardial perfusion single photon emission computed tomography in patients with major extracardiac findings by computed tomography for attenuation correction

Clinic Value of Myocardiac Perfusion Imaging in Coronary Risk Assessment in Patients Planning Total Joint Arthroplasty

Myocardial perfusion imaging with PET

Prognostic utility of 99mTc-MIBI single photon emission computerized tomography myocardial perfusion imaging in patients with ischemia and non-obstructive coronary artery disease

Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization